1,087
Views
16
CrossRef citations to date
0
Altmetric
Clinical Study

A Comparison of Sevelamer Hydrochloride with Calcium Acetate on Biomarkers of Bone Turnover in Hemodialysis Patients

, , , , , , , , & show all
Pages 701-707 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Agnieszka Makowka & Michal Nowicki. (2021) Different Effect of Lanthanum Carbonate and Sevelamer Hydrochloride on Calcium Balance in Patients with Moderate to Advanced Chronic Kidney Disease. Therapeutics and Clinical Risk Management 17, pages 1145-1151.
Read now

Articles from other publishers (15)

Marinella Ruospo, Suetonia C Palmer, Patrizia Natale, Jonathan C Craig, Mariacristina Vecchio, Grahame J Elder & Giovanni FM Strippoli. (2018) Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD). Cochrane Database of Systematic Reviews 2018:8.
Crossref
Xiuqin Yang, Qingning Bai, Yanguo Li, Haijun Liu, Haiying Guo & Xiaolei Zhang. (2017) Comparative Efficacy and Safety of Phosphate Binders in Hyperphosphatemia Patients With Chronic Kidney Disease. Journal of Parenteral and Enteral Nutrition 42:4, pages 766-777.
Crossref
Gonzalo A. Bravo-Soto & Trinidad Madrid. (2017) Sevelamer versus calcium-based phosphate binders for chronic kidney disease. Medwave 17:Suppl2, pages e6942-e6942.
Crossref
Steven Habbous, Sebastian Przech, Rey Acedillo, Sisira Sarma, Amit X. Garg & Janet Martin. (2016) The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis. Nephrology Dialysis Transplantation, pages gfw312.
Crossref
Leena Patel, Lisa M. Bernard & Grahame J. Elder. (2016) Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD. Clinical Journal of the American Society of Nephrology 11:2, pages 232-244.
Crossref
Caixia Wang, Xun Liu, Yongming Zhou, Shaomin Li, Yanbing Chen, Yanni Wang & Tanqi Lou. (2015) New Conclusions Regarding Comparison of Sevelamer and Calcium-Based Phosphate Binders in Coronary-Artery Calcification for Dialysis Patients: A Meta-Analysis of Randomized Controlled Trials. PLOS ONE 10:7, pages e0133938.
Crossref
Caroline M. Perry & Greg L. Plosker. (2014) Sevelamer Carbonate: A Review in Hyperphosphataemia in Adults with Chronic Kidney Disease. Drugs 74:7, pages 771-792.
Crossref
Adrian Covic, Jutta Passlick-Deetjen, Miroslaw Kroczak, Beatrix Büschges-Seraphin, Adrian Ghenu, Pedro Ponce, Barbara Marzell & Angel L.M. de Francisco. (2013) A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study. Nephrology Dialysis Transplantation 28:9, pages 2383-2392.
Crossref
S Alam, A Hussain, R Daiwajna & J Tan. (2013) Clinical efficacy of sevelamer hydrochloride in patients with end-stage renal disease: a retrospective study. Singapore Medical Journal 54:5, pages 263-266.
Crossref
Indranil Dasgupta, Rukshana Shroff, David Bennett-Jones & Gary McVeigh. (2013) Management of Hyperphosphataemia in Chronic Kidney Disease: Summary of National Institute for Health and Clinical Excellence (NICE) Guideline. Nephron Clinical Practice 124:1-2, pages 1-9.
Crossref
Sankar D Navaneethan, Suetonia C Palmer, Mariacristina Vecchio, Jonathan C Craig, Grahame J Elder & Giovanni FM Strippoli. (2011) Phosphate binders for preventing and treating bone disease in chronic kidney disease patients. Cochrane Database of Systematic Reviews.
Crossref
Nigel D. Toussaint, Grahame J. Elder & Peter G. Kerr. (2010) A Rational Guide to Reducing Fracture Risk in Dialysis Patients. Seminars in Dialysis 23:1, pages 43-54.
Crossref
Laura Kooienga, Linda Fried, Robert Scragg, Jessica Kendrick, Gerard Smits & Michel Chonchol. (2009) The Effect of Combined Calcium and Vitamin D3 Supplementation on Serum Intact Parathyroid Hormone in Moderate CKD. American Journal of Kidney Diseases 53:3, pages 408-416.
Crossref
James E. Novak & Lynda A. Szczech. (2009) Phosphate Binders in Chronic Kidney Disease and End-Stage Renal Disease: A Patient-Centered Approach. Seminars in Dialysis 22:1, pages 56-63.
Crossref
Margaret J. Blayney, Ronald L. Pisoni, Jennifer L. Bragg-Gresham, Juergen Bommer, Luis Piera, Akira Saito, Takashi Akiba, Marcia L. Keen, Eric W. Young & Friedrich K. Port. (2008) High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death. Kidney International 74:5, pages 655-663.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.